日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma

台湾肝癌协会中期肝细胞癌管理共识指南

Lee, I-Cheng; Wang, Hung-Wei; Teng, Wei; Lin, Tsung-Jung; Chen, Chien-Hung; Lai, Hsueh-Chou; Lee, Teng-Yu; Chang, Ching-Wei; Hung, Chao-Hung; Dai, Chia-Yen; Hung, Yi-Ping; Shen, Ying-Chun; Su, Chien-Wei; Ho, Ming-Chih; Lee, Wei-Chen; Chau, Gar-Yang; Ting, Chin-Tsung; Liang, Po-Chin; Liu, Chien-An; Chang, Pi-Yi; Chen, Kuan-Yang; Lin, Shi-Ming; Chen, Li-Tzong; Huang, Yi-Hsiang

CDK4/6 inhibitors synergize with radiotherapy to prime the tumor microenvironment and enhance the antitumor effect of anti-PD-L1 immunotherapy in triple-negative breast cancer.

CDK4/6 抑制剂与放射疗法协同作用,可启动肿瘤微环境,增强抗 PD-L1 免疫疗法在三阴性乳腺癌中的抗肿瘤效果

Yang Wen-Chi, Wei Ming-Feng, Shen Ying-Chun, Huang Chiun-Sheng, Kuo Sung-Hsin

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab

接受阿特珠单抗联合贝伐珠单抗治疗后获得持久部分缓解或持久疾病稳定的肝细胞癌患者的临床结果和组织学发现

Shen, Ying-Chun; Liu, Tsung-Hao; Nicholas, Alan; Soyama, Akihiko; Yuan, Chang-Tsu; Chen, Tse-Ching; Eguchi, Susumu; Yoshizumi, Tomoharu; Itoh, Shinji; Nakamura, Noriaki; Kosaka, Hisashi; Kaibori, Masaki; Ishii, Takamichi; Hatano, Etsuro; Ogawa, Chikara; Naganuma, Atsushi; Kakizaki, Satoru; Cheng, Chih-Hsien; Lin, Po-Ting; Su, Yung-Yeh; Chuang, Chien-Huai; Lu, Li-Chun; Wu, Chi-Jung; Wang, Hung-Wei; Rau, Kun-Ming; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Hernandez, Sairy; Finn, Richard S; Kudo, Masatoshi; Cheng, Ann-Lii

Outcomes of Post-Immunotherapy Durable Responders of Advanced Hepatocellular Carcinoma- with Emphasis on Locoregional Therapy for Oligoprogression

晚期肝细胞癌免疫治疗后持久缓解者的预后——重点关注寡转移进展的局部区域治疗

Liu, Tsung-Hao; Chen, San-Chi; Rau, Kun-Ming; Lu, Li-Chun; Lin, Po-Ting; Su, Yung-Yeh; Teng, Wei; Lai, Shiue-Wei; Yeh, Ren-Hua; Kao, Tsui-Mai; Lee, Pei-Chang; Wu, Chi-Jung; Chen, Chien-Hung; Hsu, Chih-Hung; Lin, Shi-Ming; Huang, Yi-Hsiang; Chen, Li-Tzong; Cheng, Ann-Lii; Shen, Ying-Chun

Design of Versatile Top-Down Transfer by Thermal Release Tape/Poly(methyl methacrylate) (TRT/PMMA) Bi-Supporting Layers Toward All-Transfer Transition Metal Dichalcogenide Material Based Transistor Arrays

基于热释放胶带/聚甲基丙烯酸甲酯(TRT/PMMA)双支撑层的多功能自上而下转移设计,用于全转移过渡金属二硫化物材料晶体管阵列

Shen, Ying-Chun; Wu, Bang-Kai; Tsai, Tsung-Shun; Liu, Mingjin; Chen, Jyun-Hong; Yang, Tzu-Yi; Cyu, Ruei-Hong; Chen, Chieh-Ting; Hsu, Yu-Chieh; Luo, Chai-Hung; Huang, Yu-Qi; Peng, Yu-Ren; Shen, Chang-Hong; Lin, Yen-Fu; Chiu, Po-Wen; King, Ya-Chin; Chueh, Yu-Lun

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

晚期肝细胞癌免疫治疗后脾脏体积变化与治疗结果的相关性

Chen, Bang-Bin; Liang, Po-Chin; Shih, Tiffany Ting-Fang; Liu, Tsung-Hao; Shen, Ying-Chun; Lu, Li-Chun; Lin, Zhong-Zhe; Hsu, Chiun; Hsu, Chih-Hung; Cheng, Ann-Lii; Shao, Yu-Yun

Disparity in survival benefits of pembrolizumab between Asian and non-Asian patients with advanced cancers: A systematic review and meta-regression analysis

亚洲和非亚洲晚期癌症患者接受帕博利珠单抗治疗后生存获益的差异:系统评价和荟萃回归分析

Peng, Shang-Hsuan; Lin, Ching-Hung; Chen, I-Chun; Shen, Ying-Chun; Chang, Dwan-Ying; Chen, Tom Wei-Wu; Huang, Shu-Min; Hu, Fu-Chang; Lu, Yen-Shen

Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study

在晚期实体恶性肿瘤患者中使用isatuximab联合cemiplimab靶向CD38和PD-1:一项I/II期开放标签、多中心研究的结果

Zucali, Paolo Andrea; Lin, Chia-Chi; Carthon, Bradley C; Bauer, Todd M; Tucci, Marcello; Italiano, Antoine; Iacovelli, Roberto; Su, Wu-Chou; Massard, Christophe; Saleh, Mansoor; Daniele, Gennaro; Greystoke, Alastair; Gutierrez, Martin; Pant, Shubham; Shen, Ying-Chun; Perrino, Matteo; Meng, Robin; Abbadessa, Giovanni; Lee, Helen; Dong, Yingwen; Chiron, Marielle; Wang, Rui; Loumagne, Laure; Lépine, Lucie; de Bono, Johann

Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy

肿瘤浸润组织驻留记忆CD8 T细胞在接受免疫治疗的肝细胞癌患者中的预测或预后作用有限

Shen, Ying-Chun; Yeh, Ching-Ping; Jeng, Yung-Ming; Hsu, Chiun; Hsu, Chih-Hung; Lin, Zhong-Zhe; Shao, Yu-Yun; Lu, Li-Chun; Liu, Tsung-Hao; Chen, Chien-Hung; Cheng, Ann-Lii

An Exploratory Study for the Association of Gut Microbiome with Efficacy of Immune Checkpoint Inhibitor in Patients with Hepatocellular Carcinoma

肠道微生物群与免疫检查点抑制剂治疗肝细胞癌患者疗效关联的探索性研究

Shen, Ying-Chun; Lee, Pei-Chang; Kuo, Yu-Lun; Wu, Wei-Kai; Chen, Chieh-Chang; Lei, Chengh-Hau; Yeh, Ching-Ping; Hsu, Chiun; Hsu, Chih-Hung; Lin, Zhong-Zhe; Shao, Yu-Yun; Lu, Li-Chun; Liu, Tsung-Hao; Chen, Chien-Hung; Wu, Ming-Shiang; Huang, Yi-Hsiang; Cheng, Ann-Lii